Guangdong Hongjing Optoelectronic Technology Inc.
301479
Longkou Union Chemical
301209
Zhejiang Realsun Chemical
301212
4
NEW JCM GROUP
300157
5
Shenzhen S-king Intelligent Equipment
688328
US Stock MarketDetailed Quotes
BDMD Baird Medical Investment Holdings
- 5.950
- +0.240+4.20%
Close Apr 28 16:00 ET
- 5.950
- 0.0000.00%
Post 16:23 ET
216.35MMarket Cap148.75P/E (TTM)
6.250High5.698Low45.45KVolume5.840Open5.710Pre Close273.16KTurnover0.43%Turnover Ratio148.75P/E (Static)36.36MShares13.52052wk High6.40P/B63.30MFloat Cap1.05052wk Low--Dividend TTM10.64MShs Float13.520Historical High--Div YieldTTM9.67%Amplitude1.050Historical Low6.010Avg Price1Lot Size
About Baird Medical Investment Holdings Company
Baird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.
Company Profile
SymbolBDMD
Company NameBaird Medical Investment Holdings
Listing DateDec 13, 2021
Founded2023
CEOMs. Haimei Wu
MarketNASDAQ
Fiscal Year Ends12-31
AddressBaide Building, Building 11,No. 11 Rongtong Street,Room 202, 2nd Floor, Yuexiu District
CityGuangzhou
ProvinceGuangdong
CountryChina
Zip Code510000
Phone86-20-82185926
Company Executives
- Name
- Position
- Salary
- Haimei Wu
- Chairwoman of the Board and Chief Executive Officer
- --
- Quan Qiu
- Director and Chief Administrative Officer
- --
- Kun Seng Ng
- Chief Financial Officer and Company Secretary
- --
- Rongjian Lu
- Co-Chief Technical Officer and Deputy General Manager
- --
- Hailong Sun
- Co-Chief Technical Officer and Technical Department Manager
- --
- Wei Xu
- Merchandising Department Manager
- --
- Jin Xu
- Quality Assurance Department Manager
- --
- Jianwei Yuan
- Production Department Manager
- --
- Wei Hou
- Director, Vice General Manger and Director, Sales
- --
- Professor Dr. Mingzhao Michael Xing, M.D.
- Independent Director
- --
- Professor Dr. Jianguo Ma, PhD
- Independent Director
- --
- Steven T. Halverson
- Independent Director
- --
- Joseph Ragan
- Independent Director
- --
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀